NCT06134921

Brief Summary

The present study will use transcranial electrical stimulation (tES) with conventional physical therapy in sub-acute (at least 2 weeks after stroke onset) to chronic stroke within 2 years to investigate the effect on cortical activity and upper and lower limb motor function. The findings may support the usage of tES for improving brain activity and motor function in a clinic setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2023

Completed
13 days until next milestone

Study Start

First participant enrolled

November 15, 2023

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

1.1 years

First QC Date

November 2, 2023

Last Update Submit

February 20, 2026

Conditions

Keywords

transcranial electrical stimulationstrokeelectroencephalographyrehabilitation

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Assessment (FMA) of upper and lower extremities

    The Fugl-Meyer Assessmen is used to quantify motor impairment and recovery post-stroke. The participants will use their unaffected side to perform first, and then subsequently perform their affected side in each movement 3 times. The best movement will be scored. The best performance was scored through direct observation as follows: 0=could not perform, 1= performed partially, and 2= performed fully. There was a total score of 100 (66 and 34 points for the upper and lower limbs, respectively

    Baseline, post-intervention at week 5, 1-month and 3-month after post-intervention

Secondary Outcomes (8)

  • Brain symmetry index (BSI)

    Baseline, post-intervention at week 5, 1-month and 3-month after post-intervention

  • Absolute power

    Baseline, post-intervention at week 5, 1-month and 3-month after post-intervention

  • Timed Up and Go test

    Baseline, post-intervention at week 5, 1-month and 3-month after post-intervention

  • Five-Time Sit to Stand Test

    Baseline, post-intervention at week 5, 1-month and 3-month after post-intervention

  • Spatiotemporal gait variables

    Baseline, post-intervention at week 5, 1-month and 3-month after post-intervention

  • +3 more secondary outcomes

Study Arms (3)

Active tDCS and conventional physical therapy program

EXPERIMENTAL

Participants will receive Active tDCS for 30 minutes prior conventional physical therapy program. They will be asked to perform this combination therapy for 15 sessions, occurring three times a week for five weeks.

Device: transcranial direct current stimulation (Active)Other: Conventional physical therapy program

Active tACS and conventional physical therapy program

EXPERIMENTAL

Participants will receive Active tACS for 30 minutes prior conventional physical therapy program. They will be asked to perform this combination therapy for 15 sessions, occurring three times a week for five weeks.

Device: transcranial alternating current stimulation (active)Other: Conventional physical therapy program

Sham stimulation and conventional physical therapy program

SHAM COMPARATOR

Participants will receive sham stimulation for 30 minutes prior conventional physical therapy program. They will be asked to perform this combination therapy for 15 sessions, occurring three times a week for five weeks.

Device: transcranial electrical stimulation (sham)Other: Conventional physical therapy program

Interventions

Electrode placement based on the international 10 - 20 electroencephalography electrode system for the cathodal electrode will be applied over the contralesional hemisphere. In contrast, an anodal electrode will be applied over the ipsilesional hemisphere on the primary motor cortex (C3 or C4). Participants will be asked to sit comfortably during stimulation. In the Active-tDCS group, participants will receive real tDCS with intensity 2.0 mA for 30 minutes, with a 30-second ramp-up and ramp-down.

Also known as: tDCS (Active), innk; Neurophet, Korea
Active tDCS and conventional physical therapy program

Electrode placement based on the international 10 - 20 electroencephalography electrode system for the cathodal electrode will be applied over the contralesional hemisphere. In contrast, an anodal electrode will be applied over the ipsilesional hemisphere on the primary motor cortex (C3 or C4). Participants will be asked to sit comfortably during stimulation.

Also known as: tACS (Active), innk; Neurophet, Korea
Active tACS and conventional physical therapy program

Electrode placement based on the international 10 - 20 electroencephalography electrode system for applied the cathodal electrode will be applied over the contralesional hemisphere. In contrast, an anodal electrode will be applied over the ipsilesional hemisphere on the primary motor cortex (C3 or C4). Participants will be asked to sit comfortably during stimulation. In the Sham group, participants will receive sham stimulation with intensity 2.0 mA for 1 minute, with a 30-second ramp-up and ramp-down, and no stimulation until the end of 30 minutes of stimulation. Electrodes will remain for 30 minutes.

Also known as: Sham stimulation, innk; Neurophet, Korea
Sham stimulation and conventional physical therapy program

A conventional physical therapy program will be provided after 30 minutes of stimulation immediately. The program will be provided for both upper and lower limbs which consist of stretching exercise, active exercise, and functional exercise.

Active tACS and conventional physical therapy programActive tDCS and conventional physical therapy programSham stimulation and conventional physical therapy program

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke individuals aged 18 - 80 years.
  • A first-ever unilateral ischemic or hemorrhagic stroke.
  • Stroke onset from at least 2 weeks - 2 years.
  • Having modified Rankin scale (mRS) 1-4
  • Ability to communicate, follow, and understand the instruction.

You may not qualify if:

  • Presence of any neurological antecedent, unstable medical conditions or condition that may increase risk of stimulation such as epilepsy and seizure, and history of brain surgery.
  • Presence of metal implantation, intracranial shunt, cochlear implantation, or cardiac pacemakers.
  • Presence of opened wound or infectious wound around the scalp.
  • Moderate pain in any joint of the upper or lower paretic limb (numerical pain rating score \> 4/10).
  • History of receiving non-invasive brain stimulation within the past 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy, Mahidol University

Salaya, Nakonpathom, 73170, Thailand

Location

MeSH Terms

Conditions

Ischemic StrokeHemorrhagic StrokeStroke

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2023

First Posted

November 18, 2023

Study Start

November 15, 2023

Primary Completion

December 30, 2024

Study Completion

April 30, 2025

Last Updated

February 24, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations